• OPEN AN ACCOUNT
Indian Indices
Sensex
78,669.55 30.52
( 0.04%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,705.00 -657.02
(-1.02%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Coral Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524506
INE683E01017
585.7422969
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
12.32
199.17
EPS(TTM)
Face Value()
Div & Yield %
45.27
10
0.36
 

NCL Industries consolidated net profit rises 505.77% in the March 2026 quarter
Jun 01,2026
Net profit of NCL Industries rose 505.77% to Rs 41.98 crore in the quarter ended March 2026 as against Rs 6.93 crore during the previous quarter ended March 2025. Sales rose 6.50% to Rs 399.63 crore in the quarter ended March 2026 as against Rs 375.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 278.53% to Rs 95.39 crore in the year ended March 2026 as against Rs 25.20 crore during the previous year ended March 2025. Sales rose 4.40% to Rs 1422.08 crore in the year ended March 2026 as against Rs 1362.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales399.63375.25 6 1422.081362.10 4
OPM %12.776.27 -13.368.76 -
PBDT58.3828.02 108 202.53120.55 68
PBT43.0113.58 217 147.0466.48 121
NP41.986.93 506 95.3925.20 279